We are live on ! Find out more
GP

GSK plc Portfolio holdings

AUM $602M
This Fund
S&P 500
This Quarter Est. Return
+4.24%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$602M
AUM Growth
+$3.07M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
97.52%
Holding
13
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRSP icon
1
CRISPR Therapeutics
CRSP
$5.74B
$176M 29.17%
3,220,627
– –
WVE icon
2
Wave Life Sciences
WVE
$1.02B
$106M 17.6%
18,245,691
– –
VIR icon
3
Vir Biotechnology
VIR
$1.91B
$87.1M 14.47%
8,550,954
– –
BNTX icon
4
BioNTech
BNTX
$28B
$82.8M 13.75%
889,824
– –
IDYA icon
5
IDEAYA Biosciences
IDYA
$4.03B
$49.7M 8.25%
1,333,333
– –
CYTK icon
6
Cytokinetics
CYTK
$10.8B
$29M 4.82%
340,434
– –
LYEL icon
7
Lyell Immunopharma
LYEL
$358M
$21.3M 3.53%
1,512,659
– –
SPRO icon
8
Spero Therapeutics
SPRO
$70.5M
$20.3M 3.37%
9,190,606
– –
NKTX icon
9
Nkarta
NKTX
$197M
$8.92M 1.48%
3,150,732
– –
FULC icon
10
Fulcrum Therapeutics
FULC
$294M
$6.54M 1.09%
1,785,714
– –
BCYC
11
Bicycle Therapeutics
BCYC
$303M
$6.49M 1.08%
1,529,561
– –
CVRX icon
12
CVRx
CVRX
$81M
$5.18M 0.86%
1,007,583
– –
RGNX icon
13
Regenxbio
RGNX
$619M
$3.25M 0.54%
271,456
– –

Similar funds

FIC
Family Investment Center Saint Joseph, Missouri $602M AUM 19.6% 1-Year Est. Return
WCA
Westover Capital Advisors Wilmington, Delaware $602M AUM 37.09% 1-Year Est. Return
PWP
Precedent Wealth Partners Houston, Texas $601M AUM 23.36% 1-Year Est. Return
F1I
Fund 1 Investments Rincon, Puerto Rico $603M AUM 62.42% 1-Year Est. Return
OPWM
Oakwell Private Wealth Management Austin, Texas $603M AUM 24.07% 1-Year Est. Return
FRM
Fox Run Management Greenwich, Connecticut $603M AUM 32% 1-Year Est. Return
PCTC
Perkins Coie Trust Company Seattle, Washington $603M AUM 23.96% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $603M AUM 111.06% 1-Year Est. Return

GSK plc's Q2 2026 Portfolio in Review

As of Q2 2026, GSK plc held 13 positions worth $602M, up 0.51% from $599M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 0%. GSK plc opened no new positions and made no exits, leaving the 13-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • GSK plc's ten largest holdings make up 98% of its $602M portfolio in Q2 2026.
  • GSK plc opened 0 new positions and closed 0 in Q2 2026.
  • GSK plc's portfolio value rose 0.51% quarter-over-quarter to $602M.

Based on GSK plc's 13F filing for Q2 2026, filed 13 Aug 2026.